Powerful” new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and ...
A registered nurse demonstrates how to prepare an IV infusion of Leqembi, a drug for Alzheimer's disease, at a UCLA clinic in January. Some physicians say they will not prescribe the medication.
The U.S. Food and Drug Agency is not really a singular agency. In practice, it operates more like five or more “FDAs” — each covering drugs, devices, food, cosmetics, or tobacco — combined into one. A ...
Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer's drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions of the drug gave her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results